Frequently asked questions References STEP 1 Trial: Semaglutide 2.4 mg for Weight Management (NEJM, 2021) GLP-1 Receptor Agonists: Mechanism and Clinical Use (PubMed) Semaglutide Prescribing Trends (JAMA Network Open, 2023) FDA Drug Shortage Database: Semaglutide Wegovy Prescribing Information (FDA) Endocrine Society Guidelines: Pharmacological Management of Obesity CDC: Healthy Weight Loss Safety Profile of GLP-1 RAs (PubMed, 2022) Glycogen and Water Weight (PubMed) Lean Mass Preservation During Weight Loss (PubMed) Medullary Thyroid Carcinoma Risk and GLP-1 RAs (PubMed)
This one was conducted on rats, and they found no significant difference in weight loss between the two groups of test rats
Unlike drugs that target the GLP-1 hormone, eloralintide targets amylin, a hormone that slows stomach emptying
Inflammation of the pancreas (pancreatitis)
There are also just some overall kind of downsides
In the context of resistance training in elderly subjects with sarcopenia, collagen peptide supplementation in combination with resistance training has been shown to further improve body composition by increasing fat-free mass, muscle strength, and reducing fat mass [6]
